Our team assists with new WHO guidelines for treatment of hepatitis B -- read more here

Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center Announce New Director of Communications and Marketing

Doylestown, April 8, 2020 − The Hepatitis B Foundation, a global nonprofit, recently appointed Edward F. Tate III, a Newtown resident, as director of communications and marketing.

Along with leading the foundation’s communications and marketing, Tate also will handle those functions for the Baruch S. Blumberg Institute and the Pennsylvania Biotechnology Center (PABC). The Hepatitis B Foundation created both the world-renowned Blumberg Institute and the PABC to expand its research toward a cure goal. The PABC now is among the nation’s best life sciences incubators, according to a 2018 study from the International Business Innovation Association. The Blumberg Institute has become one of the nation’s leading centers for translational research, particularly for hepatitis B and liver cancer.

All three organizations are innovative and integrated nonprofits that share a campus in Doylestown.

“Ed is a welcome addition to the Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center, especially during this challenging time, when clear communication is critical,” said Timothy M. Block, Ph.D., President and CEO of all three nonprofit organizations. “His experience and expertise will help us strengthen and grow our local and national communications.”

Tate comes to the foundation from a pharmaceutical and medical technology trade association. Previously he was director of communications for Rutgers University’s Office of Research and Economic Development, executive vice president of a Philadelphia-area public relations agency and director of media relations for Educational Testing Service in Princeton.

About the Hepatitis B Foundation: The Hepatitis B Foundation is the nation’s leading nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to www.hepb.org, read our blog at hepb.org/blog, follow us on Twitter @HepBFoundation, find us on Facebook at facebook.com/hepbfoundation or call 215‐489‐4900.